Hong Wu

机构：Heritage Foundation, University of Alberta, Peking University, Shenzhen Bay Laboratory, Heritage Medical Research Clinic, Second Affiliated Hospital of Jilin University, Center for Life Sciences, First Affiliated Hospital Zhejiang University · ORCID：0000-0001-7545-7919

发表论文 250 篇 · 总被引 34724 次 · h-index 102

代表论文

• DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities (2022 · Experimental & Molecular Medicine · 被引 276)
• TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism (2020 · Nature Communications · 被引 163)
• Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment (2022 · Nature Communications · 被引 129)
• Nonbone Marrow CD34 + Cells Are Crucial for Endothelial Repair of Injured Artery (2021 · Circulation Research · 被引 74)
• Regulation of the tumor suppressor PTEN in triple-negative breast cancer (2021 · Cancer Letters · 被引 65)
• MicroRNA-124 regulates cardiomyocyte apoptosis and myocardial infarction through targeting Dhcr24 (2019 · Journal of Molecular and Cellular Cardiology · 被引 61)